CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The aim of this study is to compare the safety and efficacy of SHR3680 with bicalutamide in the treatment of patients with hormone sensitive prostate...
Phase 3
Wesoła, Weigla, Poland and 66 other locations
The objectives of this study are to evaluate the feasibility and safety of [99mTc]Tc-PSMA-T4 in the diagnosis and treatment planning of prostate...
Warszawa, Lelechowska 5, Poland and 2 other locations
patients with progressive metastatic castration-resistant prostate cancer (mCRPC).The following assessment of prostate cancer...
Phase 3
Warszawa, Poland and 57 other locations
therapy in participants with metastatic castration resistant prostate cancer (mCRPC). There will be ten cohorts in this study: Coho...
Phase 1, Phase 2
Warsaw, Poland and 32 other locations
plus docetaxel in participants with metastatic castration resistant prostate cancer (mCRPC), all participants will receive the doce...
Phase 3
Warszawa, Poland and 249 other locations
The purpose of this study is to evaluate the efficacy and safety of apalutamide in adult men with high-risk non-metastatic castration-resistant prostate...
Phase 3
Warszawa, Poland and 388 other locations
to radiographic progression-free survival (rPFS) per 1) Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 for soft tissue and/or Prostate...
Phase 3
Warszawa, Poland and 322 other locations
prednisone/prednisolone compared with placebo plus abiraterone and prednisone/prednisolone in participants with metastatic castrate-resistant prostate...
Phase 3
Warszawa, Poland and 183 other locations
A Phase 1 Dose Escalation and Expanded Cohort Study Of PF-06821497 In The Treatment Of Adult Patients With Relapsed/Refractory Small Cell Lung Cancer...
Phase 1
Warszawa, Poland and 100 other locations
is to evaluate the effectiveness, safety and tolerability of nivolumab followed by ipilimumab, in subjects with metastatic castration resistant prostate...
Phase 2
Warszawa, Poland and 58 other locations
Clinical trials
Research sites
Resources
Legal